jueves, 6 de diciembre de 2018

GSK buys cancer biotech Tesaro for $5.1B - STAT

GSK buys cancer biotech Tesaro for $5.1B - STAT

Cancer Briefing



GSK buys cancer biotech Tesaro for $5.1B

By ADAM FEUERSTEIN


VIRGINIA COMMONWEALTH UNIVERSITY LIBRARIES
Chatter about the biotech Tesaro seeking a sale has swirled repeatedly over the past year. It turned out to be true.

No hay comentarios: